|
CN111617048A
|
|
Erlotinib sustained-release preparation for treating non-small cell lung cancer
|
|
CN111714469A
|
|
Thymalfasin preparation and preparation method thereof
|
|
CN111686082A
|
|
Phosphorophosphaproflavo fumarate preparation and preparation method thereof
|
|
CN109485575A
|
|
A kind of preparation method of ticagrelor chiral intermediate
|
|
CN108685859A
|
|
One kind preparation of sodium containing Glycididazole and preparation method thereof
|
|
CN103864665A
|
|
Preparation method of bazedoxifene acetate
|
|
CN103787984A
|
|
Preparation method of Ticagrelor intermediate 4, 6-dichloro-5-nitro-2-(propylthio) pyrimidine
|
|
CN103222962A
|
|
Injection esomeprazole composition and preparation method thereof
|
|
CN103113351A
|
|
Method for preparing optically pure chiral sulfoxide compound
|
|
CN103127006A
|
|
Dexlansoprazole composition for injection and preparation method thereof
|
|
CN102552252A
|
|
Medicine preparation of temozolomide and preparation method thereof
|
|
CN102241670A
|
|
Preparation method of high-purity chiral sulphoxide compound
|
|
CN102138903A
|
|
Everolimus solid oral medicinal composition
|
|
CN102058519A
|
|
Voriconazole slow-release suppository and preparation method thereof
|
|
CN101966157A
|
|
Decitabine sustained release microsphere and preparation method thereof
|
|
CN101926779A
|
|
Gemcitabine solid lipid nanospheres, preparation method thereof and use thereof
|
